Lucy Wang joined the Ropes & Gray corporate department in 2021, with a focus on intellectual property transactions, including in connection with licensing and collaborations, mergers and acquisitions and other strategic commercial transactions.
Lucy also maintains an active pro bono practice, representing asylum seekers in the U.S. and assisting pro bono partner organizations with research in connection with international wildlife crime.
During law school, Lucy served as a line editor and was on the submissions team for the Harvard International Law Journal. She also worked on licensing and privacy matters while participating in her school’s Cyberlaw Clinic. Additionally, she worked as a judicial intern for Justice Jon B. Streeter at the California Court of Appeal, First Appellate District in San Francisco.
Experience
Licensing and Collaborations
- Represented a leading biopharmaceutical company in its strategic license and collaboration with a biotechnology company developing innovative antiviral therapeutics.
Mergers, Acquisitions and Investments
Represented and advised PE investors, PE-backed acquirers, strategic acquirers and strategic sellers in a variety of sectors, including software, digital tech and fintech, in the context of mergers and acquisitions, asset transactions, investments and carve-outs. Representative deals include:
- Represented CIVC Partners in its significant investment in Cary Street Partners Financial, a leading independent wealth management firm.
- Represented General Atlantic in a significant growth investment in U.S. Urology Partners.
- Represented Great Gray Group, an independent leader in retirement solutions and the parent company of Great Gray Trust Company, in its acquisitions of Retirement Plan Advisory Group (“RPAG").
- Represented GI Partners and TA Associates in a strategic growth investment in Egnyte, a provider of secure content collaboration and governance solutions.
- Represented Rubicon Founders in its majority investment in Horizon Infusions, Ohio's largest network of ambulatory infusion centers.
- Represented Eversource Energy in a definitive agreement to sell Aquarion Water Company for approximately $2.4 billion to the Aquarion Water Authority.
- Represented Rubicon Founders in its $165 million strategic growth investment in Caidya.
- Represented Qorvo, a provider of core technologies for radio frequency solutions, in the sale of its United Silicon Carbide subsidiary and the silicon carbide junction field-effect transistor (SiC JFET) technology business to sensing technology firm onsemi for $115 million in cash.
- Represented Audax Private Equity in its acquisition of the Clinical Services business of Avantor Inc.
- Represented TPG in several transactions, including:
- in its acquisition of ClaimsXten, Change Healthcare’s claims-editing business, from UnitedHealth Group for $2.2 billion.
- its $1.4 billion acquisition of Nextech Systems, a provider of clinical and administrative healthcare technology solutions for specialty physician practices.
- Represented DIRECTV in an agreement to acquire EchoStar's video distribution business DISH, including DISH TV and Sling TV, through a debt exchange transaction.
- Represented Genstar Capital on its $585 million all-cash sale of 2-10 Home Buyers Warranty to Frontdoor.
- Represented BV Investment Partners in its investment in CallTower, an international leader in delivering cloud-based enterprise-class communications, contact center and collaboration solutions.
- Represented Bloomberg in its acquisition of Broadway Technology, a provider of front-office fintech technology.
- Advised Charlesbank Capital Partners in its acquisition of Titan Cloud Software, a provider of environmental compliance, advanced fuel analytics and facility management software solutions for convenience stores, fuel carriers and service providers.
- Represented CIRCOR International in its $1.6 billion sale to KKR.
- Advised GI Partners in its $1.05 billion acquisition of Atlas Technical Consultants, a leading provider of infrastructure and environmental solutions.
Capital Markets
- Represented The Duckhorn Portfolio, Inc. in its 2022 follow-on equity offering.
- Represented TransMedics Group, Inc. in its 2022 follow-on equity offering and its 2023 convertible notes offering.